Duncker Streett & Co’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-100
Closed -$18.3K 489
2023
Q2
$18.3K Hold
100
﹤0.01% 367
2023
Q1
$13.3K Hold
100
﹤0.01% 387
2022
Q4
$7.94K Hold
100
﹤0.01% 425
2022
Q3
$6K Hold
100
﹤0.01% 412
2022
Q2
$5K Hold
100
﹤0.01% 424
2022
Q1
$8K Buy
+100
New +$6.83K ﹤0.01% 415
2020
Q4
Sell
-2,000
Closed -$44K 518
2020
Q3
$44K Buy
+2,000
New +$51K 0.01% 332

Other funds holding ACLS

Duncker Streett & Co's ACLS Position: Q3 2023 in Review

Duncker Streett & Co sold out of Axcelis (ACLS) in Q3 2023, closing a stake of 100 shares — an estimated $18.3K sold.

Duncker Streett & Co first reported a position in ACLS in Q3 2020 and held it in 7 quarters. The position peaked at $44K in Q3 2020. 420 funds tracked by Wall St. Rank hold ACLS as of Q3 2023.

  • Duncker Streett & Co reported no remaining Axcelis position as of Q3 2023 after selling out during the quarter.
  • Duncker Streett & Co sold 100 Axcelis shares in Q3 2023, an estimated $18.3K.
  • Duncker Streett & Co first reported a position in Axcelis in Q3 2020 and held it in 7 quarters.
  • Duncker Streett & Co's Axcelis position peaked at $44K in Q3 2020.
  • 420 funds tracked by Wall St. Rank held Axcelis as of Q3 2023.

Based on Duncker Streett & Co's 13F filing for Q3 2023, filed 26 Oct 2023.